480 related articles for article (PubMed ID: 2477443)
21. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
Enk AH; Angeloni VL; Udey MC; Katz SI
J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
[TBL] [Abstract][Full Text] [Related]
23. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
24. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
25. On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo.
McKinney EC; Streilein JW
J Immunol; 1989 Sep; 143(5):1560-4. PubMed ID: 2788187
[TBL] [Abstract][Full Text] [Related]
26. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
[TBL] [Abstract][Full Text] [Related]
27. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
[TBL] [Abstract][Full Text] [Related]
28. Differences in surface phenotype between cytolytic and non-cytolytic CD4+ T cells. MHC class II-specific cytotoxic T lymphocytes lack Leu 8 antigen and express CD2 in high density.
Takada S; Koide J; Engleman EG
J Immunol; 1989 May; 142(9):3038-44. PubMed ID: 2468710
[TBL] [Abstract][Full Text] [Related]
29. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody.
Rosenberg AS; Finbloom DS; Maniero TG; Van der Meide PH; Singer A
J Immunol; 1990 Jun; 144(12):4648-50. PubMed ID: 2112572
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
Tyler JD; Steinmuller D
J Immunol; 1981 May; 126(5):1759-63. PubMed ID: 7012238
[TBL] [Abstract][Full Text] [Related]
31. Acceptance of related and unrelated cardiac allografts in neonatally tolerized mice is cardio-specific and transferable by regulatory CD4+ T cells.
Hofmann B; Tao K; Mai L; West LJ
J Heart Lung Transplant; 2004 Sep; 23(9):1069-76. PubMed ID: 15454173
[TBL] [Abstract][Full Text] [Related]
32. Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
Rosenberg AS; Singer A
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7739-42. PubMed ID: 2459716
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
34. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
Williams IR; Perry LL
J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
[TBL] [Abstract][Full Text] [Related]
35. Requirement of CD4 T cells for skin graft rejection against thymus leukemia (TL) antigen and multiple epitopes on the TL molecule recognized by CD4 T cells.
Tsuji K; Obata Y; Takahashi T; Arata J; Nakayama E
J Immunol; 1997 Jul; 159(1):159-66. PubMed ID: 9200451
[TBL] [Abstract][Full Text] [Related]
36. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts.
Gill RG; Rosenberg AS; Lafferty KJ; Singer A
J Immunol; 1989 Oct; 143(7):2176-8. PubMed ID: 2506278
[TBL] [Abstract][Full Text] [Related]
37. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
[TBL] [Abstract][Full Text] [Related]
38. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
[TBL] [Abstract][Full Text] [Related]
39. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
[TBL] [Abstract][Full Text] [Related]
40. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
